Literature DB >> 21896903

Analysis of the functional contributions of Asn233 in metallo-β-lactamase IMP-1.

Nicholas G Brown1, Lori B Horton, Wanzhi Huang, Sompong Vongpunsawad, Timothy Palzkill.   

Abstract

Metallo-β-lactamases, such as IMP-1, are a major global health threat, as they provide for bacterial resistance to a wide range of β-lactam antibiotics, including carbapenems. Understanding the molecular details of the enzymatic process and the sequence requirements for function are essential aids in overcoming β-lactamase-mediated resistance. An asparagine residue is conserved at position 233 in approximately 67% of all metallo-β-lactamases. Despite its conservation, the molecular basis of Asn233 function is poorly understood and remains controversial. It has previously been shown that mutations at this site exhibit context-dependent sequence requirements in that the importance of a given amino acid depends on the antibiotic being tested. To provide a more thorough examination as to the function and sequence requirements at this position, a collection of IMP-1 mutants encoding each of the 19 possible amino acid substitutions was generated. The resistance levels toward four β-lactam antibiotics were measured for Escherichia coli containing each of these mutants. The sequence requirements at position 233 for wild-type levels of resistance toward two cephalosporins were the most relaxed, while there were more stringent sequence requirements for resistance to ampicillin or imipenem. Enzyme kinetic analysis and determinations of steady-state protein levels indicated that the effects of the substitutions on resistance are due to changes in the kinetic parameters of the enzyme. Taken together, the results indicate that substitutions at position 233 significantly alter the kinetic parameters of the enzyme, but most substituted enzymes are able to provide for a high level of resistance to a broad range of β-lactams.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21896903      PMCID: PMC3232802          DOI: 10.1128/AAC.00340-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  45 in total

1.  Multiple sequence alignment with the Clustal series of programs.

Authors:  Ramu Chenna; Hideaki Sugawara; Tadashi Koike; Rodrigo Lopez; Toby J Gibson; Desmond G Higgins; Julie D Thompson
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

2.  Substrate binding and catalytic mechanism of class B beta-lactamases: a molecular modelling study.

Authors:  C Prosperi-Meys; J Wouters; M Galleni; J Lamotte-Brasseur
Journal:  Cell Mol Life Sci       Date:  2001-12       Impact factor: 9.261

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

Review 4.  Beyond the target pathogen: ecological effects of the hospital formulary.

Authors:  Ellie J C Goldstein
Journal:  Curr Opin Infect Dis       Date:  2011-02       Impact factor: 4.915

5.  The release of enzymes from Escherichia coli by osmotic shock and during the formation of spheroplasts.

Authors:  H C Neu; L A Heppel
Journal:  J Biol Chem       Date:  1965-09       Impact factor: 5.157

6.  Mechanism of action of the lexA gene product.

Authors:  R Brent; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

7.  Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties.

Authors:  J S Kahan; F M Kahan; R Goegelman; S A Currie; M Jackson; E O Stapley; T W Miller; A K Miller; D Hendlin; S Mochales; S Hernandez; H B Woodruff; J Birnbaum
Journal:  J Antibiot (Tokyo)       Date:  1979-01       Impact factor: 2.649

8.  Vectors bearing a hybrid trp-lac promoter useful for regulated expression of cloned genes in Escherichia coli.

Authors:  E Amann; J Brosius; M Ptashne
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

9.  Insight into the mechanism of the IMP-1 metallo-beta-lactamase by molecular dynamics simulations.

Authors:  Peter Oelschlaeger; Rolf D Schmid; Jürgen Pleiss
Journal:  Protein Eng       Date:  2003-05

10.  Olivanic acids, a family of beta-lactam antibiotics with beta-lactamase inhibitory properties produced by Streptomyces species. I. Detection, properties and fermentation studies.

Authors:  D Butterworth; M Cole; G Hanscomb; G N Rolinson
Journal:  J Antibiot (Tokyo)       Date:  1979-04       Impact factor: 2.649

View more
  19 in total

1.  Crystal structure of the mobile metallo-β-lactamase AIM-1 from Pseudomonas aeruginosa: insights into antibiotic binding and the role of Gln157.

Authors:  Hanna-Kirsti S Leiros; Pardha S Borra; Bjørn Olav Brandsdal; Kine Susann Waade Edvardsen; James Spencer; Timothy R Walsh; Orjan Samuelsen
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  Molecular mechanisms of substrate recognition and specificity of New Delhi metallo-β-lactamase.

Authors:  Jiachi Chiou; Thomas Yun-Chung Leung; Sheng Chen
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

Review 3.  Metallo-β-lactamase structure and function.

Authors:  Timothy Palzkill
Journal:  Ann N Y Acad Sci       Date:  2012-11-16       Impact factor: 5.691

Review 4.  B1-Metallo-β-Lactamases: Where Do We Stand?

Authors:  Maria F Mojica; Robert A Bonomo; Walter Fast
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

5.  Understanding the determinants of substrate specificity in IMP family metallo-β-lactamases: the importance of residue 262.

Authors:  Kevin M Pegg; Eleanor M Liu; Alex C George; Alecander E LaCuran; Christopher R Bethel; Robert A Bonomo; Peter Oelschlaeger
Journal:  Protein Sci       Date:  2014-08-20       Impact factor: 6.725

6.  Structural Insights into TMB-1 and the Role of Residues 119 and 228 in Substrate and Inhibitor Binding.

Authors:  Susann Skagseth; Tony Christopeit; Sundus Akhter; Annette Bayer; Ørjan Samuelsen; Hanna-Kirsti S Leiros
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

7.  Mutagenesis of zinc ligand residue Cys221 reveals plasticity in the IMP-1 metallo-β-lactamase active site.

Authors:  Lori B Horton; Sreejesh Shanker; Rose Mikulski; Nicholas G Brown; Kevin J Phillips; Ernest Lykissa; B V Venkataram Prasad; Timothy Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

8.  Crystal structures of Pseudomonas aeruginosa GIM-1: active-site plasticity in metallo-β-lactamases.

Authors:  Pardha Saradhi Borra; Ørjan Samuelsen; James Spencer; Timothy R Walsh; Marit Sjo Lorentzen; Hanna-Kirsti S Leiros
Journal:  Antimicrob Agents Chemother       Date:  2012-12-03       Impact factor: 5.191

9.  The sequence-activity relationship between metallo-β-lactamases IMP-1, IMP-6, and IMP-25 suggests an evolutionary adaptation to meropenem exposure.

Authors:  Eleanor M Liu; Kevin M Pegg; Peter Oelschlaeger
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

10.  2-Substituted 4,5-dihydrothiazole-4-carboxylic acids are novel inhibitors of metallo-β-lactamases.

Authors:  Pinhong Chen; Lori B Horton; Rose L Mikulski; Lisheng Deng; Sandeep Sundriyal; Timothy Palzkill; Yongcheng Song
Journal:  Bioorg Med Chem Lett       Date:  2012-08-10       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.